Suppr超能文献

相似文献

1
Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2.
Nat Chem Biol. 2023 Feb;19(2):206-217. doi: 10.1038/s41589-022-01159-4. Epub 2022 Oct 24.
2
Mitochondrial [2Fe-2S] ferredoxins: new functions for old dogs.
FEBS Lett. 2023 Jan;597(1):102-121. doi: 10.1002/1873-3468.14546. Epub 2022 Dec 7.
3
Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesis.
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11775-80. doi: 10.1073/pnas.1004250107. Epub 2010 Jun 14.
5
Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis.
Biochim Biophys Acta. 2012 Feb;1823(2):484-92. doi: 10.1016/j.bbamcr.2011.11.002. Epub 2011 Nov 10.
6
FDX1 regulates cellular protein lipoylation through direct binding to LIAS.
J Biol Chem. 2023 Sep;299(9):105046. doi: 10.1016/j.jbc.2023.105046. Epub 2023 Jul 13.
7
FDX1 Is Required for the Biogenesis of Mitochondrial Cytochrome c Oxidase in Mammalian Cells.
J Mol Biol. 2023 Dec 1;435(23):168317. doi: 10.1016/j.jmb.2023.168317. Epub 2023 Oct 17.
8
FDX1 regulates cellular protein lipoylation through direct binding to LIAS.
bioRxiv. 2023 Feb 4:2023.02.03.526472. doi: 10.1101/2023.02.03.526472.
10
Functional characterization of Fdx1: evidence for an evolutionary relationship between P450-type and ISC-type ferredoxins.
J Mol Biol. 2011 Nov 11;413(5):940-51. doi: 10.1016/j.jmb.2011.09.010. Epub 2011 Sep 16.

引用本文的文献

2
Protein lipoylation in cancer: metabolic reprogramming and therapeutic potential.
Cell Death Discov. 2025 Sep 2;11(1):420. doi: 10.1038/s41420-025-02718-z.
3
Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma.
Front Oncol. 2025 Jul 30;15:1555858. doi: 10.3389/fonc.2025.1555858. eCollection 2025.
4
D-cysteine impairs tumour growth by inhibiting cysteine desulfurase NFS1.
Nat Metab. 2025 Aug 12. doi: 10.1038/s42255-025-01339-1.
6
Engineered RAP-anchored copper-escorting liposomes for FDX1-targeted cuproptosis in glioblastoma therapy‌.
Theranostics. 2025 Jul 2;15(15):7802-7819. doi: 10.7150/thno.115723. eCollection 2025.
7
Nanoparticles induced cuproptosis to enhance antitumor immunotherapy.
J Nanobiotechnology. 2025 Jul 28;23(1):544. doi: 10.1186/s12951-025-03616-3.
8
Ferroptosis in ocular diseases: mechanisms, crosstalk with other cell death pathways, and therapeutic prospects.
Front Med (Lausanne). 2025 Jul 8;12:1608975. doi: 10.3389/fmed.2025.1608975. eCollection 2025.
9
Magnetic hyperthermia in oncology: Nanomaterials-driven combinatorial strategies for synergistic therapeutic gains.
Mater Today Bio. 2025 Jul 9;33:102070. doi: 10.1016/j.mtbio.2025.102070. eCollection 2025 Aug.
10
Tanshinone IIA induces oxidative stress in trophoblast cells and enhances copper dependent death.
Sci Rep. 2025 Jul 11;15(1):25012. doi: 10.1038/s41598-025-07238-5.

本文引用的文献

1
Copper induces cell death by targeting lipoylated TCA cycle proteins.
Science. 2022 Mar 18;375(6586):1254-1261. doi: 10.1126/science.abf0529. Epub 2022 Mar 17.
2
Roles of Ferredoxin-Dependent Proteins in the Apicoplast of Plasmodium falciparum Parasites.
mBio. 2021 Feb 22;13(1):e0302321. doi: 10.1128/mbio.03023-21. Epub 2022 Feb 15.
3
N-terminal tyrosine of ISCU2 triggers [2Fe-2S] cluster synthesis by ISCU2 dimerization.
Nat Commun. 2021 Nov 25;12(1):6902. doi: 10.1038/s41467-021-27122-w.
4
Recombination of 2Fe-2S Ferredoxins Reveals Differences in the Inheritance of Thermostability and Midpoint Potential.
ACS Synth Biol. 2020 Dec 18;9(12):3245-3253. doi: 10.1021/acssynbio.0c00303. Epub 2020 Nov 23.
5
Mechanistic concepts of iron-sulfur protein biogenesis in Biology.
Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118863. doi: 10.1016/j.bbamcr.2020.118863. Epub 2020 Sep 30.
6
Mitochondrial [4Fe-4S] protein assembly involves reductive [2Fe-2S] cluster fusion on ISCA1-ISCA2 by electron flow from ferredoxin FDX2.
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20555-20565. doi: 10.1073/pnas.2003982117. Epub 2020 Aug 12.
7
From Synthesis to Utilization: The Ins and Outs of Mitochondrial Heme.
Cells. 2020 Feb 29;9(3):579. doi: 10.3390/cells9030579.
8
Evolutionary Relationships Between Low Potential Ferredoxin and Flavodoxin Electron Carriers.
Front Energy Res. 2019;7. doi: 10.3389/fenrg.2019.00079. Epub 2019 Aug 23.
9
Mechanisms of Mitochondrial Iron-Sulfur Protein Biogenesis.
Annu Rev Biochem. 2020 Jun 20;89:471-499. doi: 10.1146/annurev-biochem-013118-111540. Epub 2020 Jan 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验